Zydus Cadila gets USFDA nod to market anti-dementia tablets News News / News 7 years ago 988 Views comments "Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Memantine Hydrochloride tablets USP, 5mg and 10mg... Read more
News Air India net loss reduces to Rs 3,643 cr; operating profit rises in 2016-17 News / News - 7 years ago
News Catalonia heads for a referendum: All you need to know about the centuries-old struggle News / News - 7 years ago
News GIC Re valued at Rs 80,000 crore; $1.7 billion IPO largest in insurance News / News - 7 years ago
Comments